a mild trendp ~ 0.1
Recombinant TLR4 alone had no notable impact, the anti-CD14 antibody suggested a mild trend toward ( p ~ 0.1) inhibition of uptake, whereas recombinant MD-2 inhibited ( p ≤ 0.045) only HAdV-D26 ( Figure S3A ).
Recombinant TLR4 alone had no notable impact, the anti-CD14 antibody suggested a mild trend toward ( p ~ 0.1) inhibition of uptake, whereas recombinant MD-2 inhibited ( p ≤ 0.045) only HAdV-D26 ( Figure S3A ).